Vaccine-Preventable Conditions: Disparities in Hospitalizations Affecting Rural Communities in the Southeast United States
Abstract
:1. Introduction
2. Data and Methods
2.1. Data Sources
2.2. Statistical Analysis
2.3. Multiple Regression
3. Results
3.1. A–Rates of Individual Conditions
3.2. B–Rates by Metropolitan Status
3.3. C–Social Vulnerability, Socioeconomics, Rurality, and Longitudinal Trend
3.4. D–COVID-19
4. Discussion
Study Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- World Health Organization. Vaccines and Immunization. Available online: https://www.who.int/health-topics/vaccines-and-immunization#tab=tab_1 (accessed on 15 January 2025).
- Dominguez, A.; Castilla, J.; Godoy, P.; Delgado-Rodriguez, M.; Martin, V.; Saez, M.; Soldevila, N.; Quintana, J.M.; Mayoral, J.M.; Astray, J.; et al. Effectiveness of pandemic and seasonal influenza vaccines in preventing pandemic influenza-associated hospitalization. Vaccine 2012, 30, 5644–5650. [Google Scholar] [CrossRef] [PubMed]
- Ferdinands, J.M.; Gaglani, M.; Martin, E.T.; Middleton, D.; Monto, A.S.; Murthy, K.; Silveira, F.P.; Talbot, H.K.; Zimmerman, R.; Alyanak, E.; et al. Prevention of Influenza Hospitalization Among Adults in the United States, 2015–2016: Results from the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN). J. Infect. Dis. 2019, 220, 1265–1275. [Google Scholar] [CrossRef] [PubMed]
- Foster, D.A.; Talsma, A.; Furumoto-Dawson, A.; Ohmit, S.E.; Margulies, J.R.; Arden, N.H.; Monto, A.S. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. Am. J. Epidemiol. 1992, 136, 296–307. [Google Scholar] [CrossRef] [PubMed]
- Liang, J.L.; Tiwari, T.; Moro, P.; Messonnier, N.E.; Reingold, A.; Sawyer, M.; Clark, T.A. Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 2018, 67, 1–44. [Google Scholar]
- Winter, K.; Cherry, J.D.; Harriman, K. Effectiveness of Prenatal Tetanus, Diphtheria, and Acellular Pertussis Vaccination on Pertussis Severity in Infants. Clin. Infect. Dis. 2017, 64, 9–14. [Google Scholar] [CrossRef]
- Blecker, S.; Jones, S.A.; Petrilli, C.M.; Admon, A.J.; Weerahandi, H.; Francois, F.; Horwitz, L.I. Hospitalizations for Chronic Disease and Acute Conditions in the Time of COVID-19. JAMA Intern. Med. 2021, 181, 269–271. [Google Scholar] [CrossRef]
- Lyhne, C.N.; Bjerrum, M.; Riis, A.H.; Jorgensen, M.J. Interventions to Prevent Potentially Avoidable Hospitalizations: A Mixed Methods Systematic Review. Front. Public Health 2022, 10, 898359. [Google Scholar] [CrossRef]
- Agopian, A.; Young, H.; Quinlan, S.; Rice, M.M. Factors Associated with the Uptake of Rotavirus and Pneumococcal Conjugate Vaccines among Children in Armenia: Implications for Future New Vaccine Introductions. Vaccines 2023, 11, 1719. [Google Scholar] [CrossRef]
- Marasović Šušnjara, I.; Mijaković, M.; Jurčev Savičević, A. The Influence of the COVID-19 Pandemic on Hospitalizations for Ambulatory Care-Sensitive Conditions in Split-Dalmatia County, Croatia. Medicina 2024, 60, 523. [Google Scholar] [CrossRef]
- de Moraes, E.V.; Pires, M.C.; Costa, A.A.A.; Nunes, A.G.S.; de Amorim, C.L.; Manenti, E.R.F.; Lucas, F.B.; Rodrigues, F.D.; Anschau, F.; do Nascimento, G.F.; et al. Comprehensive statistical analysis reveals significant benefits of COVID-19 vaccination in hospitalized patients: Propensity score, covariate adjustment, and feature importance by permutation. BMC Infect. Dis. 2024, 24, 1052. [Google Scholar] [CrossRef]
- Williamson, G.; Ahmed, B.; Kumar, P.S.; Ostrov, B.E.; Ericson, J.E. Vaccine-preventable diseases requiring hospitalization. Pediatrics 2017, 140, e20170298. [Google Scholar]
- Weissman, J.S.; Gatsonis, C.; Epstein, A.M. Rates of Avoidable Hospitalization by Insurance Status in Massachusetts and Maryland. JAMA-J. Am. Med. Assoc. 1992, 268, 2388–2394. [Google Scholar] [CrossRef]
- Booker, M.; Purdy, S. Towards new definitions of avoidable hospital admissions. Br. J. Gen. Pract. 2022, 72, 464–465. [Google Scholar] [CrossRef]
- Committee on Monitoring Access to Personal Health Care Services. Access to Health Care in America; National Academy Press: Washington, DC, USA, 1993. [Google Scholar]
- Centers for Disease Control. Vaccine-Preventable Adult Diseases. Available online: https://www.cdc.gov/vaccines-adults/diseases/index.html (accessed on 15 January 2025).
- Zhang, W.; Johnson, K.R. Geographic Variation in Preventable Hospitalizations among US Children with Autism. Children 2023, 10, 1228. [Google Scholar] [CrossRef]
- Centers for Disease Control. NCHS Urban-Rural Classification Scheme for Counties. Available online: https://www.cdc.gov/nchs/data-analysis-tools/urban-rural.html (accessed on 1 January 2025).
- Centers for Disease Control. Agency for Toxic Substances and Disease Registry. Available online: https://www.atsdr.cdc.gov/index.html (accessed on 15 January 2025).
- Doherty, M.T.; Aris, E.; Servotte, N.; Beck, E. Capturing the value of vaccination: Impact of vaccine-preventable disease on hospitalization. Aging Clin. Exp. Res. 2022, 34, 1551–1561. [Google Scholar] [CrossRef]
- Hartmann, M.; Servotte, N.; Aris, E.; Doherty, T.M.; Salem, A.; Beck, E. Burden of vaccine-preventable diseases in adults (50+) in the United States: A retrospective claims analysis. BMC Public Health 2024, 24, 2960. [Google Scholar] [CrossRef]
- Bushong, L.C.; Welch, P. Critical healthcare for older adults post Hurricane Ian in Florida, United States. J. Public Health Policy 2023, 44, 674–684. [Google Scholar] [CrossRef]
- Centers for Disease Control. Clinical Overview of Chickenpox (Varicella). Available online: https://www.cdc.gov/chickenpox/hcp/clinical-overview/index.html (accessed on 15 January 2025).
- Centers for Disease Control. Pneumococcal Disease: Causes and How It Spreads. Available online: https://www.cdc.gov/pneumococcal/causes/index.html (accessed on 15 January 2025).
- Zhou, F.; Jatlaoui, T.C.; Leidner, A.J.; Carter, R.J.; Dong, X.; Santoli, J.M.; Stokley, S.; Daskalakis, D.C.; Peacock, G. Health and Economic Benefits of Routine Childhood Immunizations in the Era of the Vaccines for Children Program—United States, 1994–2023. Morb. Mortal. Wkly. Rep. 2024, 73, 682–685. [Google Scholar]
- Goje, O.; Kapoor, A. Meeting the challenge of vaccine hesitancy. Cleve Clin. J. Med. 2024, 91, S50–S56. [Google Scholar] [CrossRef]
- Neely, S.R.; Eldredge, C.; Ersing, R.; Remington, C. Vaccine Hesitancy and Exposure to Misinformation: A Survey Analysis. J. Gen. Intern. Med. 2022, 37, 179–187. [Google Scholar] [CrossRef]
- Wilson, S.L.; Wiysonge, C. Social media and vaccine hesitancy. BMJ Glob. Health 2020, 5, e004206. [Google Scholar] [PubMed]
- Broadbent, J.J. Vaccine hesitancy: Misinformation on social media. BMJ 2019, 366, l4457. [Google Scholar] [CrossRef] [PubMed]
- Douthit, N.; Kiv, S.; Dwolatzky, T.; Biswas, S. Exposing some important barriers to health care access in the rural USA. Public Health 2015, 129, 611–620. [Google Scholar] [CrossRef] [PubMed]
- Laditka, J.N.; Laditka, S.B.; Probst, J.C. Health care access in rural areas: Evidence that hospitalization for ambulatory care-sensitive conditions in the United States may increase with the level of rurality. Health Place 2009, 15, 731–740. [Google Scholar] [CrossRef]
- Lazar, M.; Davenport, L. Barriers to Health Care Access for Low Income Families: A Review of Literature. J. Community Health Nurs. 2018, 35, 28–37. [Google Scholar] [CrossRef]
- Goel, K.; Vasudevan, L. Disparities in healthcare access and utilization and human papillomavirus (HPV) vaccine initiation in the United States. Hum. Vaccin. Immunother. 2021, 17, 5390–5396. [Google Scholar] [CrossRef]
- Cosby, A.G.; McDoom-Echebiri, M.M.; James, W.; Khandekar, H.; Brown, W.; Hanna, H.L. Growth and Persistence of Place-Based Mortality in the United States: The Rural Mortality Penalty. Am. J. Public Health 2019, 109, 155–162. [Google Scholar] [CrossRef]
- Koppaka, R.; Wharton, M.; Lindley, M.C.; Kohli, J.; Morita, J. Increasing equity in adult immunization through community-level action. Health Aff. Sch. 2023, 1, qxad071. [Google Scholar] [CrossRef]
- Kaul, R.; Leidner, A.J.; Chesson, H.W. Trends in costs of routinely recommended vaccines in the United States, 2001–2023. Vaccine 2025, 47, 126667. [Google Scholar]
- Ndugga, N.; Hill, L.; Artiga, S.; Haldar, S. Latest data on COVID-19 vaccinations by race/ethnicity. Kais Fam. Found 2021, 72, 1–8. [Google Scholar]
- Ventola, C.L. Immunization in the United States: Recommendations, Barriers, and Measures to Improve Compliance: Part 1: Childhood Vaccinations. Pharm. Ther. 2016, 41, 426–436. [Google Scholar]
- Nanyonjo, A.; Nelson, D.; Sayers, E.; Lall, P.; Vernon-Wilson, E.; Tetui, M.; Grindrod, K.; Kane, R.; Gussy, M.; Siriwardena, N. Community efforts to promote vaccine uptake in a rural setting: A qualitative interview study. Health Promot. Int. 2023, 38, daad088. [Google Scholar] [CrossRef] [PubMed]
- Misra, R.; Kirk, B.; Shawley-Brzoska, S.; Totzkay, D.; Morton, C.; Kuhn, S.; Harris, M.; McMillion, M.; Darling, E. Educational Intervention to Increase COVID-19 Vaccine Uptake in Rural Patients with Chronic Diseases: Lessons Learned from An Innovative Academic-Community Partnership. Int. J. Environ. Res. Public Health 2024, 21, 71. [Google Scholar] [CrossRef] [PubMed]
- Jessica, K.; Isabella, O.; James, F.; Jemesa, T.; Rachel, D.; Litiana, V.; Luisa, V.; Kylie, J.; Julie, L.; Holly, S.; et al. Training health workers and community influencers to be Vaccine Champions: A mixed-methods RE-AIM evaluation. BMJ Glob. Health 2024, 9, e015433. [Google Scholar] [CrossRef]
- Phan, C.; Mercado, B.; Travis, J.; Webb, G. Identifying the Predictors of Pediatric Vaccine Uptake during the COVID-19 Pandemic. COVID 2024, 4, 495–505. [Google Scholar] [CrossRef]
- Zhang, Y.; Xie, Y.J.; Yang, L.; Cheung, K.; Zhang, Q.; Li, Y.; Hao, C.; Wang, H.H.X.; Zhou, Q.; Leung, A.Y.M. Community-based participatory research (CBPR) approaches in vaccination promotion: A scoping review. Int. J. Equity Health 2024, 23, 227. [Google Scholar] [CrossRef]
- Talbird, S.E.; Carrico, J.; La, E.M.; Carias, C.; Marshall, G.S.; Roberts, C.S.; Chen, Y.-T.; Nyaku, M.K. Impact of Routine Childhood Immunization in Reducing Vaccine-Preventable Diseases in the United States. Pediatrics 2022, 150, e2021056013. [Google Scholar] [CrossRef]
- Columbia University Mailman School of Public Health. The Relationship Between Vaccines and Herd Immunity. Available online: https://www.publichealth.columbia.edu/news/relationship-between-vaccines-herd-immunity (accessed on 15 January 2025).
- Chiricuzio, S. Public libraries tackle telehealth challenges. Libr. J. 2022, 4, 1–9. [Google Scholar]
Pre-School-Aged Children | Children, 5–19 Years of Age | Adults, 20+ Years of Age | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Year | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 |
Diphtheria | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Poliomyelitis | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Measles | 0 | 0 | 2.6 | 0.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Mumps | 0 | 0 | 1.7 | 0.9 | 0 | 0.9 | 0.9 | 0 | 1.1 | 1.1 | 2.0 | 1.4 | 0 | 0 | 0 | 0.3 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
Rubella | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Chickenpox | 4.4 | 7.0 | 6.1 | 3.5 | 0.9 | 3.7 | 1.8 | 6.2 | 2.0 | 1.4 | 2.0 | 2.0 | 1.1 | 0 | 0.8 | 1.1 | 3 | 4 | 5 | 4 | 3 | 2 | 2 | 2 |
Hib | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Pneumococcal | 71 | 69 | 131 | 280 | 57 | 44 | 60 | 46 | 19 | 20 | 40 | 68 | 13 | 6 | 12 | 14 | 48 | 55 | 130 | 414 | 92 | 41 | 45 | 47 |
Hepatitis B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tetanus | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Whp-Cough | 39 | 40 | 34 | 45 | 20 | 0 | 2 | 33 | 0.6 | 0.3 | 0.8 | 1.4 | 0.3 | 0 | 0 | 2.1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 |
Hepatitis A | 0.9 | 0.9 | 1.7 | 1.8 | 0 | 1.8 | 0.9 | 1.8 | 1.4 | 1.1 | 3.9 | 6.4 | 1.4 | 2.5 | 3.5 | 1.9 | 24.6 | 28.6 | 42.2 | 126 | 42.3 | 15.6 | 18.5 | 10.4 |
HPV High-Risk | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0 | 0.1 | 0 | 0 | 0.1 | 0.1 | 0.1 |
Meningococcal | 1.8 | 1.8 | 3.5 | 2.6 | 1.8 | 1.8 | 0.9 | 0.9 | 0.6 | 0.6 | 0.6 | 0.3 | 0 | 0 | 0.8 | 1.1 | 0.6 | 0.7 | 0.8 | 0.6 | 0.8 | 0.5 | 2.1 | 0.8 |
Rotavirus | 99 | 93 | 59 | 80 | 11 | 23 | 69 | 75 | 8 | 12 | 3 | 6 | 0 | 1 | 7 | 9 | 2.2 | 4.3 | 2.1 | 3.3 | 0.2 | 0.9 | 4.3 | 6.6 |
RSV | 29 | 11 | 8 | 3 | 0 | 4 | 10 | 5 | 2 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0.8 | 0.4 | 0.2 | 0.2 | 0.1 | 0.4 | 0.2 | 0.2 |
Shingles | 0.9 | 2.6 | 1.7 | 0.9 | 1.8 | 2.8 | 3.6 | 0.9 | 4.0 | 2.0 | 3.9 | 2.8 | 1.6 | 2.7 | 1.9 | 1.6 | 70 | 64 | 68 | 71 | 56 | 53 | 55 | 65 |
COVID-19 | 0 | 0 | 0 | 0 | 301 | 813 | 1358 | 674 | 0 | 0 | 0 | 0 | 149.7 | 476 | 246 | 77.8 | 0 | 0 | 0 | 0 | 4880 | 8180 | 3758 | 1695 |
Post-COVID-19 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.8 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | 3.4 | 1.1 |
Legend | Lowest Value | Medium Value | Highest Value |
All conditions (Rates/1,000,000) | |||||||
---|---|---|---|---|---|---|---|
Metropolitan Area Status | All | White | Black | Other | Hispanic | Male | Female |
Pre-School-Aged Children | |||||||
Large | 141.3 | 108.2 | 215.5 | 262.5 | 69.6 | 151.8 | 130.1 |
Small/Medium | 188.0 | 164.4 | 207.2 | 280.8 | 79.5 | 188.9 | 187.7 |
Micro/Non-Core | 225.3 | 218.1 | 142.0 | 449.7 | 98.8 | 237.2 | 205.3 |
(p < 0.001) | (p < 0.01) | (p = 0.36) | (p = 0.49) | (p = 0.81) | (p = 0.14) | (p = 0.08) | |
School-Aged Children | |||||||
Large | 28.6 | 23.4 | 43.1 | 54.2 | 10.4 | 29.2 | 27.9 |
Small/Medium | 34.0 | 30.5 | 49.4 | 54.1 | 14.7 | 36.2 | 31.7 |
Micro/Non-Core | 62.1 | 57.9 | 105.4 | 31.5 | 13.6 | 62.5 | 60.3 |
(p = 0.004) | (p < 0.001) | (p = 0.15) | (p = 0.64) | (p = 0.43) | (p = 0.16) | (p = 0.19) | |
Adults | |||||||
Large | 157.8 | 158.2 | 119.5 | 188.9 | 30.9 | 163.8 | 153.7 |
Small/Medium | 182.0 | 186.7 | 147.6 | 191.2 | 36.1 | 189.2 | 176.4 |
Micro/Non-Core | 264.8 | 279.4 | 229.9 | 242.0 | 28.9 | 230.2 | 305.1 |
(p < 0.01) | (p < 0.01) | (p = 0.02) | (p = 0.68) | (p = 0.62) | (p = 0.14) | (p = 0.01) | |
Conditions related to school-mandated vaccines (Rates/1,000,000) | |||||||
Pre-School-Aged Children | |||||||
Large | 67.0 | 52.9 | 88.5 | 133.1 | 31.8 | 78.1 | 55.5 |
Small/Medium | 88.2 | 61.7 | 132.0 | 167.8 | 29.5 | 97.2 | 79.2 |
Micro/Non-Core | 101.0 | 77.0 | 77.3 | 354.3 | 50.1 | 114.1 | 84.9 |
(p = 0.31) | (p = 0.48) | (p = 0.34) | (p = 0.26) | (p = 0.47) | (p = 0.36) | (p = 0.18) | |
School-Aged Children | |||||||
Large | 19.6 | 15.5 | 35.8 | 29.8 | 5.6 | 20.4 | 18.7 |
Small/Medium | 26.1 | 23.1 | 40.9 | 38.4 | 11.4 | 25.1 | 27.4 |
Micro/Non-Core | 41.8 | 38.1 | 57.2 | 31.5 | 8.3 | 31.2 | 52.7 |
(p = 0.02) | (p = 0.03) | (p = 0.84) | (p = 0.77) | (p = 0.13) | (p = 0.52) | (p = 0.05) | |
Adults | |||||||
Large | 106.5 | 106.3 | 86.2 | 123.0 | 19.1 | 97.4 | 116.4 |
Small/Medium | 143.2 | 146.9 | 121.4 | 142.9 | 28.7 | 142.1 | 145.6 |
Micro/Non-Core | 230.6 | 242.1 | 215.5 | 207.7 | 26.0 | 192.6 | 275.5 |
(p < 0.01) | (p < 0.01) | (p < 0.01) | (p = 0.30) | (p = 0.41) | (p < 0.01) | (p < 0.01) | |
Conditions not related to school-mandated vaccines (Rates/1,000,000) | |||||||
Pre-School-Aged Children | |||||||
Large | 74.3 | 55.3 | 127.0 | 129.4 | 37.8 | 73.7 | 74.6 |
Small/Medium | 99.7 | 102.7 | 75.2 | 113.0 | 50.0 | 91.7 | 108.6 |
Micro/Non-Core | 124.2 | 141.1 | 64.7 | 95.4 | 48.7 | 123.1 | 120.4 |
(p = 0.32) | (p = 0.10) | (p = 0.35) | (p = 0.89) | (p = 0.91) | (p = 0.49) | (p = 0.65) | |
School-Aged Children | |||||||
Large | 9.0 | 7.9 | 7.3 | 24.4 | 4.8 | 8.8 | 9.2 |
Small/Medium | 7.8 | 7.4 | 8.6 | 15.6 | 3.3 | 11.1 | 4.3 |
Micro/Non-Core | 20.3 | 19.8 | 48.1 | 0.0 | 5.3 | 31.3 | 7.6 |
(p = 0.02) | (p = 0.18) | (p = 0.43) | (p < 0.01) | (p = 0.86) | (p = 0.13) | (p = 0.66) | |
Adults | |||||||
Large | 51.3 | 51.9 | 33.3 | 65.8 | 11.8 | 66.4 | 37.2 |
Small/Medium | 38.8 | 39.8 | 26.2 | 48.3 | 7.4 | 47.1 | 30.8 |
Micro/Non-Core | 34.2 | 37.3 | 14.4 | 34.3 | 2.9 | 37.6 | 29.6 |
(p = 0.08) | (p = 0.19) | (p = 0.04) | (p = 0.26) | (p < 0.01) | (p = 0.01) | (p = 0.52) |
Adults | School-Aged | Pre-School-Aged | |
---|---|---|---|
Medium Metropolitan Area | −3.55 | 1.61 | 21.28 |
(0.704) | (0.433) | (0.042) | |
Small Metropolitan Area | 18.85 | 3.58 | 2.50 |
(0.103) | (0.159) | (0.846) | |
Micropolitan Area | 3.45 | 3.77 | 14.86 |
(0.801) | (0.206) | (0.33) | |
Non-core Area | 26.16 | 7.39 | 23.74 |
(0.014) | (0.005) | (0.048) | |
SVI | 1.57 | 7.36 | 8.00 |
(<0.001) | (<0.001) | (<0.001) | |
Year | 2.29 | 0.15 | 3.46 |
(0.171) | (0.694) | (0.065) |
Rate of Inpatient Episodes per 1,000,000 (Pre-School Aged) | ||||
---|---|---|---|---|
Large Metropolitan Area | Small/Medium Metropolitan Area | Micro/Non-Core Metropolitan Area | (p-Value) | |
All groups | 344 | 403 | 460 | <0.001 |
White | 266 | 323 | 397 | <0.001 |
Black | 391 | 467 | 515 | <0.001 |
Other NWB | 790 | 918 | 1004 | <0.001 |
Hispanic | 188 | 239 | 161 | <0.001 |
Male | 313 | 333 | 413 | <0.001 |
Female | 374 | 470 | 505 | <0.001 |
Rate of Inpatient Episodes per 1,000,000 (School-Aged) | ||||
Large Metropolitan Area | Small/Medium Metropolitan Area | Micro/Non-Core Metropolitan Area | (p-value) | |
All groups | 120 | 110 | 145 | 0.002 |
White | 85 | 87 | 118 | 0.003 |
Black | 170 | 152 | 200 | <0.001 |
Other NWB | 260 | 220 | 339 | <0.001 |
Hispanic | 59 | 64 | 88 | 0.007 |
Male | 118 | 109 | 162 | <0.001 |
Female | 122 | 110 | 129 | 0.093 |
Rate of Inpatient Episodes per 1,000,000 (Adults) | ||||
Large Metropolitan Area | Small/Medium Metropolitan Area | Micro/Non-Core Metropolitan Area | (p-value) | |
All groups | 2310 | 2209 | 2513 | <0.001 |
White | 2044 | 2062 | 2333 | <0.001 |
Black | 2807 | 2717 | 2545 | 0.001 |
Other NWB | 4319 | 3745 | 6930 | <0.001 |
Hispanic | 1192 | 993 | 963 | 0.001 |
Male | 2192 | 2050 | 2659 | <0.001 |
Female | 2437 | 2378 | 2386 | 0.473 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Pracht, E.; Eldredge, C.; Tangudu, D.; Phuel, R.; Tsalatsanis, A. Vaccine-Preventable Conditions: Disparities in Hospitalizations Affecting Rural Communities in the Southeast United States. Int. J. Environ. Res. Public Health 2025, 22, 466. https://doi.org/10.3390/ijerph22040466
Pracht E, Eldredge C, Tangudu D, Phuel R, Tsalatsanis A. Vaccine-Preventable Conditions: Disparities in Hospitalizations Affecting Rural Communities in the Southeast United States. International Journal of Environmental Research and Public Health. 2025; 22(4):466. https://doi.org/10.3390/ijerph22040466
Chicago/Turabian StylePracht, Etienne, Christina Eldredge, Divyani Tangudu, Richa Phuel, and Athanasios Tsalatsanis. 2025. "Vaccine-Preventable Conditions: Disparities in Hospitalizations Affecting Rural Communities in the Southeast United States" International Journal of Environmental Research and Public Health 22, no. 4: 466. https://doi.org/10.3390/ijerph22040466
APA StylePracht, E., Eldredge, C., Tangudu, D., Phuel, R., & Tsalatsanis, A. (2025). Vaccine-Preventable Conditions: Disparities in Hospitalizations Affecting Rural Communities in the Southeast United States. International Journal of Environmental Research and Public Health, 22(4), 466. https://doi.org/10.3390/ijerph22040466